Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1510447
European Journal of Endocrinology, Vol 151, Issue 4, 447-450
Copyright © 2004 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeno, R
Right arrow Articles by Chihara, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeno, R
Right arrow Articles by Chihara, K

Clinical Studies

Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects

R Takeno, Y Okimura, G Iguchi, M Kishimoto, T Kudo, K Takahashi, Y Takahashi, H Kaji, M Ohno, H Ikuta, Y Kuroda, T Obara, H Hosoda, K Kangawa, and K Chihara

Division of Endocrinology/Metabolism, Neurology and Hematology/Oncology, Department of Clinical Molecular Medicine, Kobe University School of Medicine, Hyogo, 650-0017, Japan.

OBJECTIVE: Ghrelin is a potent peptide stimulating GH secretion. Besides its direct action on the pituitary, ghrelin has been reported to stimulate GH release via the vagal afferent nerve in rats. To examine the involvement of vagal nerve in ghrelin-induced GH secretion in humans, GH responses to ghrelin were compared between vagotomized patients with gastrectomy and normal subjects. METHODS: Ghrelin (0.2 microg/kg) or GHRH (1 microg/kg) was administered intravenously in vagotomized patients and normal subjects on separate days, and plasma GH responses to the stimuli were examined. RESULTS: Ghrelin caused a significant plasma GH rise in both vagotomized patients and normal subjects. Peak GH levels in vagotomized patients (37.5+/-16.9 ng/ml) were not different from those in normal subjects (29.9+/-23.1 ng/ml). The areas under the curve of GH response to ghrelin did not differ between the two groups. GHRH also increased GH levels, and peak GH levels and areas under the curve after GHRH stimulation were also comparable between vagotomized patients and normal subjects. CONCLUSIONS: In the present study, the involvement of the afferent vagal nerve in ghrelin-induced GH secretion was not confirmed in humans.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Strassburg, S. D. Anker, T. R. Castaneda, L. Burget, D. Perez-Tilve, P. T. Pfluger, R. Nogueiras, H. Halem, J. Z. Dong, M. D. Culler, et al.
Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E78 - E84.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C D R Murray, N M Martin, M Patterson, S A Taylor, M A Ghatei, M A Kamm, C Johnston, S R Bloom, and A V Emmanuel
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study
Gut, December 1, 2005; 54(12): 1693 - 1698.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. W. le Roux, N. M. Neary, T. J. Halsey, C. J. Small, A. M. Martinez-Isla, M. A. Ghatei, N. A. Theodorou, and S. R. Bloom
Ghrelin Does Not Stimulate Food Intake in Patients with Surgical Procedures Involving Vagotomy
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4521 - 4524.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Popovic, D. Miljic, S. Pekic, P. Pesko, M. Djurovic, M. Doknic, S. Damjanovic, D. Micic, G. Cvijovic, J. Glodic, et al.
Low Plasma Ghrelin Level in Gastrectomized Patients Is Accompanied by Enhanced Sensitivity to the Ghrelin-Induced Growth Hormone Release
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2187 - 2191.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 European Society of Endocrinology.